Publications and scholarly work
Rong M, Marques PT, Ali QZ, Morcos R, Chandran I, Qaiser F, Møller RS, Bayat A, Rubboli G, Gardella E, Reuter MS, Sands TT, Scheffer IE, Schneider A, Poduri A, Wirrell E, Nabbout R, Sullivan J, Valente K, Auvin S, Knupp KG, Brunklaus A, Aledo-Serrano Á, Andrade DM.
Variants in ATP6V0C are associated with Dravet-like developmental and epileptic encephalopathy
Epilepsia, 2025
Marin R, Rulo G, Andrade DM, Inuzuka LM, Castro MAA, Vincentiis S, Guerreiro MM, Valente KD.
A new developmental and epileptic encephalopathy: PUM1-neurodevelopmental disorder with epilepsy with myoclonic-atonic seizures
Seizure, 2025
Andrade DM, Bailey LD, Meskis MA, Hood V, Ferreira S, Dixon-Salazar T, Griffin J, Perry MS.
A survey of adult caregivers of people with developmental and epileptic encephalopathies: A long-term care planning needs assessment
Epilepsy Behav, 2025
Andrade DM.
Out with prolactin, in with neurofilament light and glial fibrillary acidic protein
Epilepsy Curr, 2025
Marques P, Moloney PB, Ji C, Zulfiqar Ali Q, Ramesh A, Goldstein DB, Barboza K, Chandran I, Rong M, Selvarajah A, Qaiser F, Lira VST, Valiante TA, Bazil CW, Choi H, Devinsky O, Depondt C, O'Brien T, Perucca P, Sen A, Dugan P, Sands TT, Delanty N, Andrade DM.
Do germline genetic variants influence surgical outcomes in drug-resistant epilepsy?
Epilepsy Res, 2024
Vasey MJ, Tai XY, Thorpe J, Jones GD, Ashby S, Hallab A, Ding D, Andraus M, Dugan P, Perucca P, Costello DJ, French JA, O'Brien TJ, Depondt C, Andrade DM, Sengupta R, Datta A, Delanty N, Jette N, Newton CR, Brodie MJ, Devinsky O, Cross JH, Sander JW, Hanna J, Besag FMC, Sen A; COVID‐19 Epilepsy COV‐E Study Group.
The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study
Epilepsia Open, 2024